XML 32 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES:    
Net income (loss) $ (249) $ 598
Adjustments to net income (loss):    
Depreciation and amortization 803 774
Loss (gain) on disposal and sale of business interests 117 (9)
Impairment expense 1,057 116
Deferred income taxes (342) 4
Loss on extinguishment of debt 95 126
Loss (gain) on sale and disposal of assets (37) 21
Other 250 278
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (40) 27
(Increase) decrease in inventory (15) (3)
(Increase) decrease in prepaid expenses and other current assets 33 (17)
(Increase) decrease in other assets (252) 1
Increase (decrease) in accounts payable and other current liabilities (98) (12)
Increase (decrease) in income tax payables, net and other tax payables 62 (124)
Increase (Decrease) in Deferred Revenue 606 25
Increase (decrease) in other liabilities 97 (30)
Net cash provided by operating activities 2,087 1,775
INVESTING ACTIVITIES:    
Capital expenditures (1,375) (1,628)
Acquisitions of business interests, net of cash and restricted cash acquired (94) (56)
Proceeds from the sale of business interests, net of cash and restricted cash sold 41 226
Proceeds from the sale of assets 17 23
Sale of short-term investments 439 524
Purchase of short-term investments (546) (572)
Contributions and loans to equity affiliates (286) (258)
Other investing (52) 30
Net cash used in investing activities (1,856) (1,711)
FINANCING ACTIVITIES:    
Borrowings under the revolving credit facilities 2,099 1,469
Repayments under the revolving credit facilities (1,515) (1,041)
Issuance of recourse debt 1,619 0
Repayments of recourse debt (1,596) (449)
Issuance of non-recourse debt 4,229 3,580
Repayments of non-recourse debt (3,451) (2,978)
Payments for financing fees (79) (69)
Distributions to noncontrolling interests (194) (255)
Payments to Acquire Additional Interest in Subsidiaries 240 0
Contributions from noncontrolling interests and redeemable security holders 0 15
Issuance of Preferred Shares in Subsidiaries 113 0
Dividends paid on AES common stock (286) (272)
Payments for financed capital expenditures (59) (126)
Other financing 17 (7)
Net cash provided by (used in) financing activities 657 (133)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (33) (28)
Net Cash Change Of Discontinued And Held For Sale Businesses (46) (65)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 809 (162)
Cash, cash equivalents and restricted cash, beginning 1,572 2,003
Cash, cash equivalents and restricted cash, ending 2,381 1,841
SUPPLEMENTAL DISCLOSURES:    
Cash payments for interest, net of amounts capitalized 618 681
Cash payments for income taxes, net of refunds 258 296
Non Cash Refinancing of Non-recourse Debt 0 1,081
sPower [Member]    
SUPPLEMENTAL DISCLOSURES:    
Reinvestment of Proceeds from Sale of Equity Method Investments 0 58
Fluence [Member] | Non-cash [Member]    
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Contributions of assets and liabilities for the Fluence transaction (see Note 19) $ 0 $ 62